quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:13:32·945d
INSIDERFiling
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Dietz Thomas John returned 69,250 shares to the company, closing all direct ownership in the company

PRTK· Paratek Pharmaceuticals Inc.
Health Care
Original source

Companies

  • PRTK
    Paratek Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • May 2UpdateJefferies$5.00
  • Apr 17UpdateBTIG Research$24.00
  • Feb 10UpdateWBB Securities$11.00
  • Nov 9UpdateHC Wainwright & Co.$27.00

Related

  • SEC934d
    SEC Form 15-12G filed by Paratek Pharmaceuticals Inc.
  • SEC941d
    SEC Form EFFECT filed by Paratek Pharmaceuticals Inc.
  • INSIDER945d
    SEC Form 4: Baylor-Henry Minnie returned 59,200 shares to the company, closing all direct ownership in the company
  • INSIDER945d
    SEC Form 4: Hoffmann Rolf K returned 84,000 shares to the company, closing all direct ownership in the company
  • INSIDER945d
    SEC Form 4: Brenner Randall B. returned 415,209 shares to the company, closing all direct ownership in the company
  • INSIDER945d
    SEC Form 4: Peterson Kristine returned 79,000 shares to the company, closing all direct ownership in the company
  • INSIDER945d
    SEC Form 4: Stein Jeffrey returned 68,625 shares to the company, closing all direct ownership in the company
  • INSIDER945d
    SEC Form 4: Haskel William M. returned 447,024 shares to the company, closing all direct ownership in the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022